These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 2475275

  • 1. Cardiac anaphylaxis. Complement activation as an amplification system.
    del Balzo U, Polley MJ, Levi R.
    Circ Res; 1989 Sep; 65(3):847-57. PubMed ID: 2475275
    [Abstract] [Full Text] [Related]

  • 2. Activation of the third complement component (C3) and C3a generation in cardiac anaphylaxis: histamine release and associated inotropic and chronotropic effects.
    del Balzo U, Polley MJ, Levi R.
    J Pharmacol Exp Ther; 1988 Sep; 246(3):911-6. PubMed ID: 2458450
    [Abstract] [Full Text] [Related]

  • 3. Effect of C3a and C5a anaphylatoxins on guinea-pig isolated blood vessels.
    Marceau F, Hugli TE.
    J Pharmacol Exp Ther; 1984 Sep; 230(3):749-54. PubMed ID: 6332191
    [Abstract] [Full Text] [Related]

  • 4. Pulmonary injury induced by C3a and C5a anaphylatoxins.
    Stimler NP, Hugli TE, Bloor CM.
    Am J Pathol; 1980 Aug; 100(2):327-48. PubMed ID: 6967702
    [Abstract] [Full Text] [Related]

  • 5. Effects of human anaphylatoxins on guinea pig atria.
    Huey R, Bloor CM, Hugli TE.
    Immunopharmacology; 1984 Dec; 8(3-4):147-54. PubMed ID: 6335143
    [Abstract] [Full Text] [Related]

  • 6. Anaphylactic actions of platelet-activating factor.
    Stimler NP, Bloor CM, Hugli TE, Wykle RL, McCall CE, O'Flaherty JT.
    Am J Pathol; 1981 Oct; 105(1):64-9. PubMed ID: 6975043
    [Abstract] [Full Text] [Related]

  • 7. Immunopharmacology of anaphylatoxin-induced bronchoconstrictor responses.
    Stimler-Gerard NP.
    Complement; 1986 Oct; 3(3):137-51. PubMed ID: 3026723
    [Abstract] [Full Text] [Related]

  • 8. Cardiac dysfunction caused by purified human C3a anaphylatoxin.
    del Balzo UH, Levi R, Polley MJ.
    Proc Natl Acad Sci U S A; 1985 Feb; 82(3):886-90. PubMed ID: 2579381
    [Abstract] [Full Text] [Related]

  • 9. Generation of anaphylatoxins through proteolytic processing of C3 and C5 by house dust mite protease.
    Maruo K, Akaike T, Ono T, Okamoto T, Maeda H.
    J Allergy Clin Immunol; 1997 Aug; 100(2):253-60. PubMed ID: 9275149
    [Abstract] [Full Text] [Related]

  • 10. Anaphylatoxin-induced release of histamine from in vitro perfused guinea pig kidney.
    Abdullah NA, Assem ES, Damerau B.
    Agents Actions; 1988 Apr; 23(3-4):181-4. PubMed ID: 2455983
    [Abstract] [Full Text] [Related]

  • 11. Role of histamine in the spasmogenic effect of the complement peptides C3a and C5a-desArg (classical anaphylatoxin).
    Sorgenfrei J, Damerau B, Vogt W.
    Agents Actions; 1982 Apr; 12(1-2):118-21. PubMed ID: 6177210
    [Abstract] [Full Text] [Related]

  • 12. Complement activation during systemic lupus erythematosus. C3a and C5a anaphylatoxins circulate during exacerbations of disease.
    Belmont HM, Hopkins P, Edelson HS, Kaplan HB, Ludewig R, Weissmann G, Abramson S.
    Arthritis Rheum; 1986 Sep; 29(9):1085-9. PubMed ID: 3489467
    [Abstract] [Full Text] [Related]

  • 13. Complement activation requirements for histamine release from human leukocytes: influence of purified C3ahu and C5ahu on histamine release.
    Hartman CT, Glovsky MM.
    Int Arch Allergy Appl Immunol; 1981 Sep; 66(3):274-81. PubMed ID: 6170591
    [Abstract] [Full Text] [Related]

  • 14. Comparative study on biological activities of various anaphylatoxins (C4a, C3a, C5a). Investigations on their ability to induce platelet secretion.
    Meuer S, Hugli TE, Andreatta RH, Hadding U, Bitter-Suermann D.
    Inflammation; 1981 Dec; 5(4):263-73. PubMed ID: 6976935
    [Abstract] [Full Text] [Related]

  • 15. The effects of the anaphylatoxins C3a and C5a on isolated mast cells from rat and man.
    Jürgensen H, Behrendt H, Damerau B, Schmutzler W.
    Agents Actions; 1986 Apr; 18(1-2):153-4. PubMed ID: 2425572
    [Abstract] [Full Text] [Related]

  • 16. Complement activation and anaphylatoxin (C3a and C5a) formation in preeclampsia and by amniotic fluid.
    Haeger M, Bengtson A, Karlsson K, Heideman M.
    Obstet Gynecol; 1989 Apr; 73(4):551-6. PubMed ID: 2784554
    [Abstract] [Full Text] [Related]

  • 17. Modulation of the immune response by anaphylatoxins.
    Morgan EL.
    Complement; 1986 Apr; 3(3):128-36. PubMed ID: 3542364
    [Abstract] [Full Text] [Related]

  • 18. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
    Langone JJ, Das C, Bennett D, Terman DS.
    J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
    [Abstract] [Full Text] [Related]

  • 19. Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a).
    Schifferli JA, Steiger G, Paccaud JP.
    Clin Exp Immunol; 1986 May; 64(2):407-14. PubMed ID: 3488858
    [Abstract] [Full Text] [Related]

  • 20. Cardiac dysfunction caused by recombinant human C5A anaphylatoxin: mediation by histamine, adenosine and cyclooxygenase arachidonate metabolites.
    del Balzo U, Sakuma I, Levi R.
    J Pharmacol Exp Ther; 1990 Apr; 253(1):171-9. PubMed ID: 1691782
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.